*NEWRECORD
RECTYPE = C
NM = bevonium
RN = 34B0471E08
N1 = 2-(hydroxymethyl)-N,N-dimethylpiperidinium benzilate
RR = 33371-53-8 (bevonium)
RR = 35517-05-6
RR = 5205-82-3
SY = Acabel|T109|T121|TRD|NRW|NLM (1971)|abbcde
SY = CG 201|T109|T121|LAB|NRW|NLM (1971)|abbcde
SY = bevonium methyl sulfate|T109|T121|NRW|NLM (1971)|abbde
SY = bevonium methylsulfate|T109|T121|NRW|NLM (1971)|990818|abbdef
SY = bevonium sulfate (1:1)|T109|T121|NRW|NLM (1971)|990818|abbdef
SY = piribenzil methyl sulfate|T109|T121|NRW|NLM (1971)|abbde
HM = Benzilates
PI = PIPERIDINES (71-81)
SO = S Afr Med J 50(1):4;1976
NM_TH = FDA SRS (2013)
NM_TH = NLM (1971)
ST = T109
ST = T121
PA = Anti-Inflammatory Agents, Non-Steroidal
FR = 1
NO = structure given in first source
DA = 19710101
MR = 20121105
UI = C000002

*NEWRECORD
RECTYPE = C
NM = insulin, neutral
RN = 12584-58-6
N1 = Insulin, 8A-L-threonine-10A-L-isoleucine-
SY = Actrapid insulin|T116|T121|TRD|NRW|NLM (1971)|abbcde
SY = Novo MC insulin|T116|T121|TRD|NRW|NLM (1971)|abbcde
SY = insulin (ox), 8(A)-L-threonine-10(A)-L-isoleucine-|T116|T121|REL|NLM (1971)|abbde
SY = neutral insulin|T116|T121|EQV|NLM (1971)|abbde
HM = Insulin, Regular, Pork
PI = *INUSLIN (1971-2013)
SO = Q J Med 1979;48(191):493
NM_TH = NLM (1971)
NM_TH = USAN (1965)
ST = T116
ST = T121
PA = Hypoglycemic Agents
FR = 253
NO = a neutral, buffered solution of pork insulin
DA = 19710101
MR = 20130507
UI = C000006

*NEWRECORD
RECTYPE = C
NM = N-acetylglucosaminylasparagine
RN = 2776-93-4
N1 = L-Asparagine, N-(2-acetylamino)-2-deoxy-beta-D-glucopyranosyl-
SY = 2-acetamido-1-(beta-L-aspartamido)-1,2-dideoxy-beta-D-glucose|T109|T123|EQV|NLM (1974)|abbde
SY = 2-acetamido-1-N-(4'-L-aspartyl)-2-deoxy-beta-D-glucopyranosylamine|T109|T123|EQV|NLM (1974)|abbde
SY = 4-N-2-acetamido-2-deoxy-beta-D-glucopyranosyl-L-asparagine|T109|T123|EQV|NLM (1974)|abbde
SY = AADG|T109|T123|EQV|NLM (1974)|abbde
SY = N(4)-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-L-asparagine|T109|T123|EQV|NLM (1974)|abbde
SY = N(4)-(2-acetamido-2-deoxyglucopyranosyl)asparagine|T109|T123|EQV|NLM (1974)|abbde
SY = N-(2-acetylamino)-2-deoxy-beta-D-glucopyranosyl-L-asparagine|T109|T123|EQV|NLM (1974)|abbde
SY = N-ADGP-Asn|T109|T123|EQV|NLM (1974)|abbde
SY = acetylglucosaminylasparagine|T109|T123|EQV|NLM (1974)|abbde
SY = asparaginylglucosamine|T109|REL|NLM (1974)|abde
SY = aspartylglucosamine|T109|T123|REL|NLM (1974)|abbde
SY = aspartylglucosylamine|T109|T123|REL|NLM (1974)|abbde
SY = aspartylglycosamine|T109|T123|REL|NLM (1974)|abbde
HM = Acetylglucosamine/analogs & derivatives
PI = *AMINOGLYCOSIDES (74-78)
PI = ASPARAGINE/*analogs (79-79)
PI = ASPARTIC ACID (74-75)
PI = ASPARTIC ACID/*analogs (80-82)
PI = ASPARTIC ACID/analogs (75-80)
SO = Am J Dis Child 127(4):561;1974
SO = Birth Defects 10(4):193;1974
SO = Birth Defects 11(6):251;1975
SO = Clin Chim Acta 91(1):75;1979
SO = Clin Sci 1980;58(2):165
SO = FEBS Lett 78(2):284;1977
SO = J Biochem(Tokyo) 84(6):1467;1978
SO = J Inherited Metab Dis 1978;1(3):95
SO = J Lab Clin Med 93(5):718;1979
SO = J Pediatr 84(3):456;1974
SO = J Pediatr 86(5):715;1975
SO = Pediatr Pol 50(8):1061;1975
NM_TH = NLM (1974)
ST = T109
ST = T123
FR = 104
NO = RN given refers to parent cpd; presence in urine characteristic of aspartylglucosaminuria; structure
DA = 19740101
MR = 20011214
UI = C000009